These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 24681766

  • 21. Myocardial perfusion improvement and mechanism after percutaneous intramyocardial septal radiofrequency ablation in obstructive hypertrophic cardiomyopathy: a study of myocardial contrast echocardiography.
    Yao L, Ta S, Wang J, Han C, Lei C, Li W, Li J, Wang B, Zhao X, Liu L.
    Int J Cardiovasc Imaging; 2024 Jul; 40(7):1483-1492. PubMed ID: 38709352
    [Abstract] [Full Text] [Related]

  • 22. [Percutaneous transluminal septal myocardial ablation: early results and long-term follow-up].
    Tekieli Ł, Pieniazek P, Podolec P, Tomkiewicz-Pajak L, Płazak W, Musiałek P, Leśniak-Sobelga A, Przewłocki T, Biernacka B, Zmudka K, Tracz W.
    Przegl Lek; 2006 Jul; 63(8):628-32. PubMed ID: 17441371
    [Abstract] [Full Text] [Related]

  • 23. Reverse remodeling after percutaneous transluminal septal myocardial ablation in severe but asymptomatic LVOT obstruction (RASTA) study: Rationale and design of transcatheter septal reduction in asymptomatic patients with severe hypertrophic obstructive cardiomyopathy.
    Arslan F, Akdim F, Ten Berg JM.
    Catheter Cardiovasc Interv; 2021 Feb 15; 97(3):488-492. PubMed ID: 32808736
    [Abstract] [Full Text] [Related]

  • 24. Peak systolic longitudinal strain of the lateral left ventricular wall improves after septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: a follow-up study using speckle tracking echocardiography.
    Faber L, Prinz C, Welge D, Hering D, Butz T, Oldenburg O, Bogunovic N, Horstkotte D.
    Int J Cardiovasc Imaging; 2011 Mar 15; 27(3):325-33. PubMed ID: 20694748
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Myocardial perfusion after percutaneous transluminal septal myocardial ablation as assessed by myocardial contrast echocardiography in patients with hypertrophic obstructive cardiomyopathy.
    Pedone C, Biagini E, Galema TW, Vletter WB, ten Cate FJ.
    J Am Soc Echocardiogr; 2006 Aug 15; 19(8):982-6. PubMed ID: 16880092
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Gated SPECT in patients with hypertrophic obstructive cardiomyopathy undergoing transcoronary ethanol septal ablation.
    Keng FY, Chang SM, Cwajg E, He ZX, Lakkis NM, Nagueh SF, Spencer WH, Verani MS.
    J Nucl Cardiol; 2002 Aug 15; 9(6):594-600. PubMed ID: 12466783
    [Abstract] [Full Text] [Related]

  • 29. Percutaneous transluminal septal myocardial ablation: past, present, and future.
    Maekawa Y, Takamisawa I, Takano H, Takayama M.
    J Cardiol; 2022 Sep 15; 80(3):211-217. PubMed ID: 34924238
    [Abstract] [Full Text] [Related]

  • 30. [Role of cardiac magnetic resonance on predicting outcome in patients with hypertrophic obstructive cardiomyopathy undergoing percutaneous transluminal septal myocardial ablation].
    Du H, Lu M, Yin G, Yin X, Jiang Y, Wang J, Chen X, Song L, Huang J, Zhang Y, Zhao S.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Aug 15; 42(8):665-9. PubMed ID: 25388340
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effect of successful alcohol septal ablation on microvascular function in patients with obstructive hypertrophic cardiomyopathy.
    Soliman OI, Geleijnse ML, Michels M, Dijkmans PA, Nemes A, van Dalen BM, Vletter WB, Serruys PW, ten Cate FJ.
    Am J Cardiol; 2008 May 01; 101(9):1321-7. PubMed ID: 18435965
    [Abstract] [Full Text] [Related]

  • 33. [Long-term outcome of patients with hypertrophic obstructive cardiomyopathy post percutaneous transluminal septal ablation].
    Zheng SW, Shi HY, Dai JJ, Chen H, Wu WH, Qiu XB.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr 24; 48(4):294-301. PubMed ID: 32370480
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography.
    Faber L, Seggewiss H, Gleichmann U.
    Circulation; 1998 Dec 01; 98(22):2415-21. PubMed ID: 9832486
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Left ventricular wall function abnormalities in patients with ankylosing spondylitis evaluated by gated myocardial perfusion scintigraphy.
    Yalcin H, Guler H, Gunay E, Yeral N, Turhanoglu A, Bolaç E, Yalcin F.
    Rev Esp Med Nucl; 2011 Dec 01; 30(5):292-6. PubMed ID: 21435747
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Site of myocardial infarction and severity of perfusion abnormalities impact on post-stress left ventricular function in patients with single-vessel disease: gated single-photon emission computed tomography methoxyisobutylisonitrile study.
    Sobic-Saranovic DP, Pavlovic SV, Beleslin BD, Petrasinovic ZR, Kozarevic NDj, Todorovic-Tirnanic MV, Ille TM, Jaksic ED, Artiko VM, Obradovic VB.
    Nucl Med Commun; 2009 Feb 01; 30(2):148-54. PubMed ID: 19077915
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.